Porocarcinoma, from the CureRays guide library. Porocarcinoma is a rare skin cancer that arises from the cells of a sweat-gland duct, usually as a slowly changing bump on the head, leg, or trunk of an older adult; most are cured by complete surgical removal, with radiation used to lower the chance of return for high-risk tumors or to treat disease that can't be fully removed. What it is. Porocarcinoma is a rare skin cancer that develops from the cells lining the duct of an eccrine sweat gland — the part of the gland that carries sweat to the skin's surface. It is the malignant counterpart of a common, harmless growth called a poroma, and it can either arise on its own or develop within a long-standing poroma that begins to change. Porocarcinoma usually appears in older adults, most often on the head and neck, the legs, or the trunk, as a raised bump or plaque that may be skin-colored, red, or brownish, and that often grows slowly over months to years. A sign that a long-standing growth may have turned cancerous is a recent change — it enlarges, bleeds, becomes tender, ulcerates, or develops an irregular surface. Most porocarcinomas remain confined to the skin and are cured when removed completely, but a minority behave more aggressively: they can recur where they started, spread to nearby lymph nodes, and, less commonly, travel to distant organs. The risk of this depends on features the pathologist assesses, such as how deeply the tumor invades, how quickly its cells are dividing, and whether it has invaded small blood or lymph vessels. The cornerstone of treatment is surgery to remove the tumor completely with a clear margin — often using a precise, margin-controlled technique (Mohs surgery) for tumors on the face or in cosmetically and functionally important areas. Radiation is used to lower the chance of recurrence for high-risk tumors, to treat lymph nodes when needed, and as the main treatment when surgery isn't possible. How radiation treats it. Radiation therapy treats porocarcinoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. Because most porocarcinomas are cured by completely removing them, radiation is used selectively — but for higher-risk tumors it is an important way to improve control. Its most common role is after surgery: when a tumor has worrying features such as deep invasion, rapidly dividing cells, or invasion of small vessels, or when it could not be removed with a comfortable margin of clear tissue, microscopic cancer cells may remain at the edges of the surgical site. Radiation treats that area to sterilize any residual disease so the cancer is less likely to return at the original site. Radiation is also directed at the lymph nodes — after they are surgically removed, or when they are involved — because the nodes draining the skin are the first place porocarcinoma tends to spread, and treating that region lowers the chance of the cancer coming back there. When surgery is not a good option, for example in a frail patient or a tumor in a difficult location, focused radiation can serve as the main treatment, controlling the tumor and relieving symptoms. Because porocarcinoma arises in the skin, the radiation can often be delivered with techniques suited to surface targets, such as low-energy X-rays or electron beams, which concentrate the dose in the skin and the tissue just beneath it while sparing deeper structures. Throughout, modern planning shapes the dose to cover the tumor or tumor bed while limiting exposure to surrounding normal skin and underlying tissue, balancing effective treatment with a good cosmetic and functional result. The ways we can treat it. Postoperative (adjuvant) radiation. Radiation to the tumor bed after surgery sterilizes microscopic disease left behind, lowering the chance of recurrence for high-risk tumors or when the margin is close. Definitive radiation. When a tumor can't be safely removed — for example, in a frail patient or a difficult location — focused radiation can control it and relieve symptoms without surgery. Nodal radiation. Radiation to the lymph node region after node surgery, or when nodes are involved, treats microscopic disease there and lowers the chance of regional recurrence. Superficial / electron-beam radiation. For tumors confined to the skin, low-energy X-rays or electron beams deliver dose to the skin surface while sparing deeper tissue, an efficient way to treat the target. Questions we hear often. How is porocarcinoma different from a harmless poroma? A poroma is a common, benign growth of the same sweat-gland duct cells, while a porocarcinoma is the cancerous version. Sometimes a porocarcinoma even develops within a long-standing poroma that begins to change. They can look similar at first, which is why a recent change in a long-standing bump — it grows, bleeds, becomes tender, ulcerates, or develops an irregular surface — is an important warning sign that should be checked. The definitive answer comes from removing the growth and examining it under the microscope, where a pathologist can tell a benign poroma from a porocarcinoma and assess how aggressive the cancer is. Will I need anything besides surgery? Often surgery alone is enough. Most porocarcinomas are confined to the skin and are cured by removing them completely with a clear margin, and many people then simply have routine skin checks. Additional treatment is added when the pathologist finds higher-risk features — deep invasion, rapidly dividing cells, or invasion of small vessels — or when the margin is close. In those cases, radiation to the area lowers the chance of the cancer returning. If there is concern the cancer may have reached the lymph nodes, those are evaluated, and radiation or further surgery may be directed there. The exact plan depends on what the removed tumor shows. Where does porocarcinoma spread if it does? Most porocarcinomas don't spread at all. When they do, the first place is usually the lymph nodes that drain the area of skin where the tumor began — which is why those nodes are examined and imaged for higher-risk tumors, and sometimes sampled with a sentinel node biopsy. Less commonly, the cancer can travel to distant organs. The chance of spread is higher for tumors that invade deeply, have many dividing cells, or involve small vessels. Catching and treating higher-risk tumors thoroughly — with complete surgery, radiation when indicated, and node evaluation — is aimed precisely at preventing this spread. This guide is informational only. It is not medical advice — please confirm anything here with your care team.